Cliff Asness's ANGO Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 251,514 shares of AngioDynamics, Inc. (ANGO) worth $2.86 M, representing 0.00% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in ANGO, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2023, adding 471,070 shares. Largest reduction occurred in Q1 2024, reducing 287,931 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's AngioDynamics (ANGO) Holding Value Over Time
Track share changes against reported price movement
Quarterly AngioDynamics (ANGO) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +25,868 | Add 11.46% | 251,514 | $11.37 |
| Q4 2025 | +155,753 | Add 222.84% | 225,646 | $12.84 |
| Q3 2025 | +707 | Add 1.02% | 69,893 | $11.17 |
| Q2 2025 | -27,150 | Reduce 28.18% | 69,186 | $9.92 |
| Q1 2025 | -67,633 | Reduce 41.25% | 96,336 | $9.39 |
| Q4 2024 | -140,492 | Reduce 46.14% | 163,969 | $9.16 |
| Q3 2024 | -5,851 | Reduce 1.89% | 304,461 | $7.78 |
| Q2 2024 | -95,983 | Reduce 23.62% | 310,312 | $6.05 |
| Q1 2024 | -287,931 | Reduce 41.48% | 406,295 | $5.87 |
| Q4 2023 | +471,070 | Add 211.09% | 694,226 | $7.84 |
| Q3 2023 | +71,120 | Add 46.78% | 223,156 | $7.31 |
| Q2 2023 | +94,948 | Add 166.32% | 152,036 | $10.43 |
| Q1 2023 | +4,888 | Add 9.36% | 57,088 | $10.34 |
| Q4 2022 | +36,023 | Add 222.68% | 52,200 | $13.77 |
| Q3 2022 | -659 | Reduce 3.91% | 16,177 | $20.46 |
| Q2 2022 | -35,396 | Reduce 67.77% | 16,836 | $19.36 |
| Q1 2022 | -60,516 | Reduce 53.67% | 52,232 | $21.54 |
| Q4 2021 | +15,715 | Add 16.20% | 112,748 | $27.58 |
| Q3 2021 | +27,409 | Add 39.37% | 97,033 | $25.94 |
| Q2 2021 | +18,038 | Add 34.97% | 69,624 | $27.13 |
| Q1 2021 | +3,950 | Add 8.29% | 51,586 | $23.40 |
| Q4 2020 | -8,025 | Reduce 14.42% | 47,636 | $15.32 |
| Q3 2020 | -15,905 | Reduce 22.22% | 55,661 | $12.06 |
| Q2 2020 | +7,890 | Add 12.39% | 71,566 | $10.17 |
| Q1 2020 | +15,175 | Add 31.29% | 63,676 | $10.43 |
| Q4 2019 | +1,086 | Add 2.29% | 48,501 | $16.02 |
| Q3 2019 | -1,404 | Reduce 2.88% | 47,415 | $18.41 |
| Q2 2019 | -12,146 | Reduce 19.92% | 48,819 | $19.68 |
| Q1 2019 | -25,621 | Reduce 29.59% | 60,965 | $22.87 |
| Q4 2018 | -15,357 | Reduce 15.06% | 86,586 | $20.13 |
| Q3 2018 | +29,953 | Add 41.61% | 101,943 | $21.74 |
| Q2 2018 | +21,009 | Add 41.21% | 71,990 | $22.24 |
| Q1 2018 | +139 | Add 0.27% | 50,981 | $17.24 |
| Q4 2017 | -14,374 | Reduce 22.04% | 50,842 | $16.64 |
| Q3 2017 | -88,235 | Reduce 57.50% | 65,216 | $17.10 |
| Q2 2017 | +4,401 | Add 2.95% | 153,451 | $16.21 |
| Q1 2017 | +12,139 | Add 8.87% | 149,050 | $17.35 |
| Q4 2016 | +51,262 | Add 59.85% | 136,911 | $16.87 |
| Q3 2016 | +85,649 | New Buy | 85,649 | $17.54 |
| Q2 2016 | -53,340 | Sold Out | 0 | $0.00 |
| Q1 2016 | +35,203 | Add 194.09% | 53,340 | $12.30 |
| Q4 2015 | +5,637 | Add 45.10% | 18,137 | $12.13 |
| Q3 2015 | -1,900 | Reduce 13.19% | 12,500 | $13.20 |
| Q1 2015 | +14,400 | New Buy | 14,400 | $17.78 |
Cliff Asness's AngioDynamics Investment FAQs
Cliff Asness first purchased AngioDynamics, Inc. (ANGO) in Q1 2015, acquiring 14,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held AngioDynamics, Inc. (ANGO) for 45 quarters since Q1 2015.
Cliff Asness's largest addition to AngioDynamics, Inc. (ANGO) was in Q4 2023, adding 694,226 shares worth $5.44 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 251,514 shares of AngioDynamics, Inc. (ANGO), valued at approximately $2.86 M.
As of the Q1 2026 filing, AngioDynamics, Inc. (ANGO) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in AngioDynamics, Inc. (ANGO) was 694,226 shares, as reported at the end of Q4 2023.